Trial Design Solutions

  1. Why Leading Cancer Research Centers Trust OpenClinica For Oncology Trials 7/16/2024

    See eight key reasons why leading cancer research centers rely on OpenClinica to navigate the intricacies of oncology trials and advance the field of cancer research.

  2. Cardiovascular, Renal And Metabolic Clinical Development 1/14/2026

    CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.

  3. Decentralized Trials Support: Direct-To-Patient Supply Management 8/25/2025

    Direct-to-patient shipments are reshaping decentralized trials by placing patient convenience at the center of study design.

  4. Home Trial Support: The Engine Powering DCT 8/10/2021

    By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.

  5. Accelerate Approval Of Novel Therapies 8/9/2023

    Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.

  6. Endocrine & Metabolic Expertise To Enable Your Success 12/7/2022

    Veristat has built a team of scientific-minded experts who have supported more than 300 projects for endocrine/metabolic disorder treatments and prepared over 30 marketing applications, 60% of which have been approved or authorized to date.

  7. Your Top Partner For Ophthalmic Drug Development 4/9/2024

    As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

  8. Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility 6/29/2021

    Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.

  9. Biorasi Rare and Urgent Disease 9/21/2021

    Read how Biorasi's speed and agility make all the difference in overcoming unique obstacles to rare disease clinical trials.

  10. Biometrics 4/28/2021

    Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.